Company / R&D Expense
Nutex Health, Inc. R&D Expense History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$285.9K
FY2021
5-year range
$285.9K / $285.9K
FY2018-FY2021
Trend
-48.7%
vs FY2020
Sector context
#168 of 167
Industrials
What the data says
Among 167 Industrials companies, Nutex Health, Inc. is in the bottom -1% for r&d expense. Declined from $768,103 to $285,880 over the past 2 years.
Based on SEC 10-K filings.
$285,880 in FY2021 with a 3-year CAGR of -19.4%.
Declined from $768,103 to $285,880 over the past 2 years.
Industrials sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -19.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -1% in IndustrialsTop 101% of 167This company $285.9K Sector average $283.8M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -19.4%, indicating a declining trend.
- In FY2021, r&d expense decreased 48.7% year-over-year.
- Ranks #168 out of 167 companies in the Industrials sector.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $285.9K | -48.7% |
| FY2020 | $557.3K | -27.5% |
| FY2019 | $768.1K | +40.9% |
| FY2018 | $545.2K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Mar 28, 2026